Zynerba Pharmaceuticals

company in Radnor, United States
Organization business Q30283745
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 3 annual filings
Revenue
$86.0K
FY2018
Net Income
-$35.04M
▲ 6.1% YoY FY2022
Assets
$55.52M
▼ 31.6% YoY FY2022
EPS (diluted)
$-0.82
▲ 13.7% YoY FY2022
$0.00$23.7K$47.3K$71.0K$94.6K FY2016: $7.2K · NI -$23.39M (-322600.1% margin)FY2017: $0.00 · NI -$32.01M (0.0% margin)FY2018: $86.0K · NI -$39.91M (-46408.3% margin) '16'17'18
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2018-12-31 · accession 0001558370-21-002669

Key Facts

  • Country: United States[1], US[2]
  • Instance of: public company[3]
  • Headquarters location: Radnor[4]
  • Stock exchange: Nasdaq[5]
  • Inception: January 1, 2014[6], 2007-01-31[7]
  • Official website: https://zynerba.com/[8]
  • Legal form: Delaware corporation[9], XTIQ[10]

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Zynerba Pharmaceuticals. Retrieved October 14, 2026, from https://4ort.xyz/entity/zynerba-pharmaceuticals
MLA “Zynerba Pharmaceuticals.” 4ort.xyz Knowledge Graph, 4ort.xyz, 14 Oct. 2026, https://4ort.xyz/entity/zynerba-pharmaceuticals.
BibTeX @misc{4ortxyz_zynerba-pharmaceuticals_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Zynerba Pharmaceuticals}}, year = {2026}, url = {https://4ort.xyz/entity/zynerba-pharmaceuticals}, note = {Accessed: 2026-10-14}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Zynerba Pharmaceuticals — https://4ort.xyz/entity/zynerba-pharmaceuticals (retrieved 2026-10-14)

Canonical URL: https://4ort.xyz/entity/zynerba-pharmaceuticals · Last refreshed: